The complex treatment including rituximab in the Management of Catastrophic Antiphospholid Syndrome with renal involvement
Abstract Background Catastrophic antiphospholipid syndrome (CAPS) is a rare, life-threatening form of antiphospholipid syndrome (APS) involving many organs and leading to their insufficiency. The pathogenesis of CAPS is associated with the presence of antiphospholipid antibodies (aPL). Typical thera...
Main Authors: | Aleksandra Rymarz, Stanisław Niemczyk |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2018-06-01
|
Series: | BMC Nephrology |
Online Access: | http://link.springer.com/article/10.1186/s12882-018-0928-z |
Similar Items
-
Noninfectious, Severe Cryoglobulinemic Vasculitis with Renal Involvement – Safety and Efficacy of Long-Term Treatment with Rituximab
by: Leśniak K, et al.
Published: (2021-07-01) -
Assessment of the correlation of commonly used laboratory tests with clinical activity, renal involvement and treatment of systemic small-vessel vasculitis with the presence of ANCA antibodies
by: Magdalena Mosakowska, et al.
Published: (2021-08-01) -
Impaired Kidney Function Associated with Increased Risk of Side Effects in Patients with Small Vessel Vasculitis Treated with Rituximab as an Induction Therapy
by: Aleksandra Rymarz, et al.
Published: (2021-02-01) -
Ocular Involvement of Granulomatosis with Polyangiitis
by: Anna Byszewska, et al.
Published: (2023-07-01) -
Protein energy-wasting associated with nephrotic syndrome – the comparison of metabolic pattern in severe nephrosis to different stages of chronic kidney disease
by: Anna Matyjek, et al.
Published: (2020-08-01)